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Critical Role of the Mesenteric Depot Versus Other
Intra-abdominal Adipose Depots in the Development of
Insulin Resistance in Young Rats
Karyn J. Catalano, Darko Stefanovski, and Richard N. Bergman
OBJECTIVE—Age-associated insulin resistance may be caused
by increased visceral adiposity and older animals appear to be
more susceptible to obesity-related resistance than young ani-
mals. However, it is unclear to what extent the portally drained
mesenteric fat depot inﬂuences this susceptibility.
RESEARCH DESIGN AND METHODS—Young high-fat–fed
and old obese rats were subjected to 0, 2, 4, or 6 weeks of caloric
restriction. Insulin sensitivity (SI) was assessed by hyperinsuline-
mic clamp and lean body mass (LBM) and total body fat were
assessed by
18O-water administration.
RESULTS—Six weeks of caloric restriction caused a similar
reduction in body weight in young and old animals (P  0.748)
that was not due to reduced subcutaneous fat or LBM, but rather
preferential loss of abdominal fat (P  0.05). Most notably,
mesenteric fat was reduced equivalently in young and old rats
after 6 weeks of caloric restriction (253%; P  0.537). Despite
similar visceral fat loss, SI improved less in old (132.76  9.80%)
than in young (182.91  12.66%) rats versus week 0. In addition,
there was signiﬁcantly more reversal of fat accumulation in the
liver in young (% reduction: 89  2) versus old (64  5) rats (P 
0.0001). Furthermore, in young rats, SI changed much more
rapidly for a given change in mesenteric fat versus other abdom-
inal depots (slope  0.53 vs. 0.27 kg/min/mg per % fat).
CONCLUSIONS—Improved SI during caloric restriction corre-
lated with a preferential abdominal fat loss. This improvement
was refractory in older animals, likely because of slower libera-
tion of hepatic lipid. Furthermore, mesenteric fat was a better
predictor of SI than other abdominal depots in young but not old
rats. These results suggest a singular role for mesenteric fat to
determine insulin resistance. This role may be related to delivery
of lipid to liver, and associated accumulation of liver fat.
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ncreased abdominal adipose mass has been of par-
ticular interest in elucidating the mechanisms of
insulin resistance. Visceral fat has been implicated
because of its distinct anatomic characteristics, be-
cause it has a circulation draining into the portal vein and
hence the liver. Compared with subcutaneous, visceral
adipocytes have a higher secretion rate of some adipo-
kines and metabolites linked to insulin resistance, includ-
ing free fatty acids (FFAs). In addition, visceral fat cells
are resistant to insulin-mediated suppression of lipolysis,
leading to elevated FFA delivery to the liver (1–3). In-
creased release of FFA and/or adipokines from the vis-
ceral depot may disrupt insulin action, most likely at the
liver, a primary site of insulin resistance in diet-induced
obesity (4,5).
Many rodent studies suggesting a linkage between vis-
ceral fat and insulin resistance have focused on the
removal of speciﬁc intra-abdominal fat depots: epididymal
and perirenal fat (6,7). However these depots do not have
the same circulation as most intra-abdominal fat depots in
larger mammals, or primates, including humans. Rodents
present three morphologically distinct fat depots: subcu-
taneous, intra-abdominal (epididymal and perirenal pads),
and portally draining “true” visceral fat (mesenteric de-
pot). Thus, removal of abdominal fat shown to inﬂuence
insulin sensitivity in rats does not necessarily mirror
visceral fat depletion in nonrodent species. It is therefore
unclear what role the mesenteric fat depot per se may play
in the development of insulin resistance in rodent models
of obesity. Furthermore, because mesenteric fat in the
rodent closely resembles visceral fat in the human, greater
experimental attention to this depot and its role in resis-
tance is required.
Although increased adiposity per se may contribute to
insulin resistance associated with aging, it is possible that
the susceptibility to obesity-linked resistance is altered by
age. In this regard, our laboratory has demonstrated that
for a given degree of intra-abdominal adiposity, old rats
have a greater decrement in insulin sensitivity compared
with young (8). It was therefore one goal of the present
study to examine the vulnerability of old versus young rats
to fat-induced insulin resistance. We tested the hypothesis
that fat reduction due to short-term caloric restriction is
less effective in enhancing insulin sensitivity in naturally
obese old animals compared with a similarly obese group
of young rats. Furthermore, we hypothesized that the
mesenteric fat depot, in particular, distinct from other
intra-abdominal fat pads, plays a pivotal role in this altered
susceptibility to resistance with age.
RESEARCH DESIGN AND METHODS
Animals. Two groups of male Fischer Brown Norway rats (F344XBN F1;
National Institute on Aging, Bethesda, MD) were used in this study: 1) young
rats (5–6 months; n  34) fed a high-fat diet (HFD) for 3 weeks and 2) old rats
(23–4 months; n  35) fed a standard chow diet ad libitum. Rats from each
group were subjected to 0, 2, 4, or 6 weeks of short-term caloric restriction.
The HFD obtained from Harlan Teklad (Madison, WI) consisted of 5.0 kcal/g,
66.5% of which was from fat (lard); 21%, from protein; and 12.5%, carbohy-
drate. Ad libitum chow–fed rats were given a standard diet provided by the
National Institutes of Health (NIH) (Diet NIH-31; 4.02 kcal/g). Once subjected
to caloric restriction, animals were fed 60% of their typical chow ad libitum
calorie per day using a NIH-31 fortiﬁed diet (3.95 kcal/g) based on feeding
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group. A separate group of young rats (5–6 months, n  8) fed the standard
diet ad libitum were used as a control group. All animals had free access to
water and were housed in the University of Southern California vivarium in
separate cages under controlled temperature and lighting (12-h light/12-h dark
cycle). All procedures were approved by the Institutional Animal Care and Use
Committee at the University of Southern California.
Surgeries. Animals were prepared for the euglycemic clamp protocol as
described previously (8). Forty-eight hours prior to the day of the experiment,
those animals on restricted diet were returned to a standard chow ad libitum
feeding regimen to prevent any acute effects of restriction on fasting state
during experiments. On the morning of the experiment (0600 h), any remain-
ing food was removed from the cage and catheters were placed. Two tail vein
catheters for infusion and one tail artery catheter for sampling were inserted
under local anesthesia (2% lidocaine; Phoenix Pharmaceuticals, St. Joseph,
MO). Sampling catheter patency was maintained by infusion of saline with 10
units/ml heparin (1.0 ml/h). Each animal underwent a hyperinsulinemic-
euglycemic clamp at 1200 h (6-h fast).
Hyperinsulinemic-euglycemic clamp. D-[3-
3H]-glucose (0.2 Ci/min;
“tracer”) began at t  240 min. Four samples to measure basal glucose
turnover were taken at t  60, 45, 30, and 15 min. At t  0, infusion of
insulin (5 mU/min/kg) was started. Samples were taken at 10-min intervals and
plasma glucose was monitored. Dextrose (20% unlabeled) was infused via the
remaining venous catheter at a variable rate to maintain euglycemia. Eugly-
cemia was deﬁned as the average basal glucose for each rat. Steady state (SS)
was deﬁned as the last 30 min of the clamp (t  120–150 min).
Body composition. A bolus of water labeled with the stable isotope
18O was
given to assess total body water, and subsequently total body fat, during the
euglycemic clamp. One basal plasma sample was taken at t  121 min,
followed by an
18O-water bolus at t  120 min (0.5 g/kg body wt). Animals
were equilibrated for 2 h and a sample was taken at t  1 min to assess
steady-state
18O levels. To determine the contribution of abdominal fat to total
body fat, three abdominal fat pads (epididymal, perirenal, and mesenteric)
were excised and weighed upon sacriﬁce.
Blood sampling. Blood samples for glucose, insulin, adiponectin, resistin,
leptin, and tracer determination were collected in tubes coated with heparin
and lithium ﬂuoride and centrifuged immediately for separation of plasma.
Samples collected for FFAs and glycerol were collected in tubes containing
diethyl p-nitrophenyl phosphate (Paraoxan) to inhibit lipoprotein lipase
within samples (9) and centrifuged immediately, and plasma was stored at
20°C until assay.
Liver triglycerides. To determine hepatic lipid content, lipid was extracted
from frozen liver samples by chloroform:methanol using an adaptation of the
Folch method (10).
Assays. Plasma glucose was measured using the automated glucose analyzer
YSI 2300 STAT Plus (Yellow Springs, OH). Insulin was assessed using an
Ultrasensitive Rat Insulin ELISA Kit from Alpco (Salem, NH). Plasma adi-
ponectin, resistin, and leptin were assayed using commercially available kits
from Alpco. Plasma nonesteriﬁed FFAs were measured using the FFA Assay
Kit from Wako Chemicals (Neuss, Germany), glycerol was measured using
Triglyceride Reagent from Sigma Diagnostics (St. Louis, MO), and triglyceride
was measured using a commercially available kit from Stanbio (Boerne, TX).
Triglyceride values were normalized per gram of liver.
To determine D-[3-
3H]-glucose, plasma samples were deproteinized with
BaOH2 and Zn2SO4 as described by Somogyi (11).
Samples for
18O water measurement were assayed by Metabolic Solutions
(Nashua, NH) using the Europa 20/20 Automated Breath Carbon Analyzer
Isotope Ratio Mass Spectrometer with an intra-assay coefﬁcient of variation of
0.2%.
Data analysis. Glucose turnover and insulin sensitivity (SI) were calculated
as previously described (8), using classic tracer dilution methodology (12), to
estimate glucose disappearance (Rd) expressed per lean body mass and
endogenous glucose production (EGP) expressed per body weight.
Total body water was determined as described previously (13,14) and
measures were corrected for a known 1% overestimation of this parameter
with the H2
18O technique (13). Lean body mass (LBM) was calculated as the
TOTAL body water/0.72 (15) and total body fat, as the difference between
body weight and LBM.
Statistics. All data are represented as means  SEMs. Within-group compar-
isons were made using ANOVA with Tukey multiple comparisons test for
individual variances. Student t or paired t tests, when appropriate, were
performed for individual comparisons. Multiple linear regression analysis was
used to assess the relationship between sensitivity and adiposity with a t test
for slope comparison between age groups. ANOVAs and regressions were
performed using MINITAB Statistical Software (State College, PA) and t tests,
using Excel 2000, with statistical signiﬁcance set at P  0.05.
RESULTS
Food intake. Using recommendations from the NIA,
young and old animals were fed a diet consisting of 41
and 47 kcal/day, respectively, during the caloric restriction
phase of the study versus 66 and 68 kcal/day in control and
fat-fed young rats, respectively (data not shown).
Body weight and composition. Although 3 weeks of
HFD in young rats (Y0) did not cause a signiﬁcant increase
in body weight, LBM, or subcutaneous fat (Y0 vs. control:
P  0.054, P  0.634, P  0.367, respectively; Table 1), it
did promote abdominal fat accretion (total abdominal fat;
90%), and the three depots comprising total abdominal
fat (epididymal, perirenal, and visceral fat) were markedly
larger (64  7%, 111  10%, 121  9%, respectively).
As expected, body weight was 1.5-fold greater in old
rats (M0) versus control and Y0 rats (M0 vs. control, Y0: P 
0.001) and although LBM was unaltered (control: 219 
24 g vs. M0: 199  6g ,P  0.445), subcutaneous fat was
markedly augmented with age (control: 132  26 g vs. M0:
307  12 g; P  0.001; data not shown). However,
percentage of LBM was reduced in older animals (239%),
whereas percentage of subcutaneous fat was increased by
61%. Abdominal fat depots were signiﬁcantly increased
with age (Table 1).
TABLE 1
Body composition for all animals used in study
Body
wt (g)
LBM
(% body wt)
Subcutaneous
fat (% body wt)
Epididymal
fat (g)
Perirenal
fat (g)
Mesenteric/
visceral fat (g)
Total
abdominal fat (g)
Control 360  10 61  73 6  7 4.40  0.26 3.06  0.22 1.58  0.08 9.04  0.51
Young
0 weeks (n  8) 385  45 2  74 4  7 7.20  0.33* 6.45  0.30* 3.49  0.14* 17.15  0.60*
2 weeks (n  8) 389  64 4  35 2  3 7.16  0.31* 5.10  0.39* 2.56  0.17* 14.82  0.78*
4 weeks (n  8) 359  95 2  54 5  5 5.00  0.48 3.44  0.65 1.47  0.17 9.90  1.27
6 weeks (n  10) 335  55 2  44 6  4 3.98  0.11 2.54  0.16 1.55  0.09 8.07  0.30
Old
0 weeks (n  9) 533  19*§ 37  0*§ 58  0*§ 9.96  0.74*§ 8.47  0.58*§ 8.43  0.79*§ 26.86  1.96*§
2 weeks (n  8) 496  13*§ 43  4* 52  4* 8.81  0.67* 7.99  0.57*§ 6.59  0.34*§ 23.39  1.19*§
4 weeks (n  10) 472  14*§ 41  2* 56  2* 7.12  0.67*§ 6.44  0.76*§ 4.02  0.31*§ 17.58  1.54*§
6 weeks (n  8) 460  11*§ 39  0* 57  0* 7.05  0.48*§ 5.47  0.47 § 3.99  0.34*§ 16.51  1.24*§
Data are means  SEMs. Body weight, LBM, subcutaneous fat, epididymal fat, perirenal fat, mesenteric/visceral fat, and the sum of the three
abdominal depots (total abdominal fat) in control rats as well as young fat-fed and old rats exposed to 0, 2, 4, and 6 weeks of caloric
restriction.*Signiﬁcant difference between control and a single experimental group as determined by Student t test, where P  0.05. §Value
signiﬁcantly differs from young rats at the same time exposure to caloric restriction using two-way ANOVA with post hoc tests where P  0.05.
K.J. CATALANO, D. STEFANOVSKI, AND R.N. BERGMAN
diabetes.diabetesjournals.org DIABETES, VOL. 59, JUNE 2010 1417Caloric restriction in young and old rats caused a
modest body weight reduction, reaching signiﬁcance by 4
weeks (young: 26.8%, P  0.05; old: 211.4%, P  0.05)
and arriving at its nadir by 6 weeks (young: 212.8%, P 
0.05; old: 213.7%, P  0.05; Table 1, Fig. 1). These changes
could not be explained by reductions in either percentage
of LBM (young: P  0.584; old: P  0.399) or percentage of
subcutaneous fat (young: P  0.624; old: P  0.355 by
ANOVA; Table 1). However, caloric restriction did effec-
tively reduce abdominal fat by 4 weeks in both young and
old rats, with no further reductions at 6 weeks (young:
45%2; old: 30%2; Fig. 1). Interestingly, obesity was
reversed slightly more in young (Y6) versus old (M6) rats
by 6 weeks for both epididymal and perirenal fat pads; in
contrast, strikingly similar reductions in the visceral fat
depot were observed over the period of 6 weeks of caloric
restriction for both young and old rats (Y6: 244  3% vs.
M6: 247  4, P  0.537; Fig. 1).
Basal plasma chemistry. Plasma glucose was unaltered
by either HFD, age, or caloric restriction (Table 2). In
contrast, 3 weeks of HFD in young rats induced signiﬁcant
basal hyperinsulinemia (171  20% from control, P 
0.012; Table 2). To a greater extent, age also provoked
basal hyperinsulinemia (M0: 2.5-fold vs. Y0, P  0.001) as
observed previously (8). Surprisingly, 6 weeks of caloric
restriction was not sufﬁcient to correct hyperinsulinemia
in either group (young vs. time: P  0.120; old vs. time: P 
0.247), although Y6 insulin was no longer different from
control (P  0.072; Table 2).
To examine indirectly the effect of caloric restriction on
the adipocyte, basal plasma FFA and glycerol were mea-
sured. No signiﬁcant trends were observed for plasma
glycerol due to either diet or age (Table 2). However, FFAs
were noticeably elevated in both young and old obese
models (Y0 vs. control: 143  7%, P  0.036; M0 vs.
control: 159  8%, P  0.008). In contrast to insulin, this
elevation was completely attenuated by 6 weeks of caloric
restriction in young and old rats (Y6 vs. control: P  0.202;
M6 vs. control: P  0.509; Table 2).
Insulin sensitivity. Glucose in all animals was success-
fully clamped to fasting levels (basal vs. SS: P  0.10; data
not shown). When exposed to hyperinsulinemia, control
animals required a steady-state glucose infusion rate
(GINF) of 24.26  1.15 mg/min/kg to maintain euglycemia
(Fig. 2A). Both HFD and age caused a signiﬁcant and
similar decrease in GINF (30–40%; SSGinf;Y 0 vs. M0, P 
0.121). After only 2 weeks of caloric restriction, GINF
increased by 43% in young rats (Y0: 14.62  0.56 vs. Y2:
20.88  0.55 mg/min/kg; P  0.001) and continued to
improve after 4 weeks reaching levels comparable with
control (Y4: 24.34  1.26 mg/min/kg vs. control; P  0.961;
Fig. 2B and C). In stark contrast, 2-week GINF for old rats
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mg/min/kg; P  0.945), and only after 6 weeks of caloric
restriction was signiﬁcant improvement observed in old
rats where GINF was not different from control (M6:
21.00  1.28 mg/min/kg vs. control; P  0.08).
As suggested by GINF, we observed 50% reduction in
whole body insulin sensitivity (SI) in obese young and old
groups compared with control rats (Fig. 3A). However, we
did not ﬁnd any notable resistance in the periphery in either
group; obese rats had similar SIR dcompared with control
rats (Y0 vs. control: P  0.105; M0 vs. control: P  0.196; Fig.
3B). Rather, both groups appeared to manifest liver resis-
tance solely as evidenced by 67 and 105% reductions in SI EGP
in Y0 and M0 rats, respectively, versus control (Fig. 3C).
TABLE 2
Basal and steady-state plasma characteristics for all animals used in study
Glucose (mM) Insulin (pM) Basal FFA (mM) SS FFA (mM) Basal glycerol (mM) SS glycerol (mM)
Control 6.15  0.13 137  17 0.30  0.05 0.02  0.01 0.14  0.02 0.11  0.01
Young
0 weeks (n  8) 6.44  0.11 234  27* 0.42  0.02* 0.14  0.03* 0.17  0.01 0.17  0.02*
2 weeks (n  8) 6.08  0.19 143  27 0.41  0.02 0.07  0.01* 0.16  0.01 0.12  0.01
4 weeks (n  8) 5.95  0.28 196  27 0.38  0.04 0.05  0.01* 0.15  0.01 0.14  0.01*
6 weeks (n  10) 6.27  0.16 190  21 0.37  0.02 0.06  0.01* 0.11  0.01 0.07  0.00*
Old
0 weeks (n  9) 6.10  0.13 349  25* 0.47  0.02* 0.14  0.02* 0.14  0.01§ 0.16  0.01*
2 weeks (n  8) 6.01  0.14 384  53*§ 0.43  0.03* 0.17  0.02*§ 0.14  0.01 0.17  0.01*§
4 weeks (n  10) 6.77  0.13*§ 421  58*§ 0.36  0.02 0.09  0.01* 0.15  0.01 0.14  0.01*
6 weeks (n  8) 6.47  0.09 298  11* 0.33  0.03 0.06  0.01* 0.13  0.01 0.13  0.01*§
Data are means  SEMs. Fasting and steady-state (SS) plasma glucose, insulin, FFAs, and glycerol in control rats as well as young fat-fed
and old rats exposed to 0, 2, 4, and 6 weeks of caloric restriction. *Signiﬁcant difference between control and a single experimental group
as determined by Student t test, where P  0.05. §Value signiﬁcantly differs from young rats at the same time exposure to caloric restriction
using two-way ANOVA with post hoc tests where P  0.05.
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young and old rats (young vs. time: P  0.001; old vs. time:
P  0.032; Fig. 3A). However young animals responded
more rapidly to fat loss than did old; young rats exhibited
signiﬁcant improvement in SI by 4 weeks of caloric restric-
tion (147% from Y0; P  0.05) versus old rats responding
only after 6 weeks (125% from M0; P  0.05). Although SI
Rd was not signiﬁcantly impaired in either young or old
obese animals, there was a signiﬁcant effect of time on
SIR d(SIR dvs. time: P  0.002) as well as age (SIR dvs. age:
P  0.008) with caloric restriction (Fig. 3B). Similarly,
SI EGP was also inﬂuenced by both time (SI EGP vs. time:
P  0.034) and age (SIR dvs. age: P  0.005; Fig. 3C). Most
notably, the changes in SI EGP in young rats during caloric
restriction exactly mirrored those changes in SI EGP in old
rats (young vs. old: P  0.128).
Although this study was not designed to measure lipid
turnover as low-dose heparin was used to maintain cath-
eter patency, we did observe that whereas control animals
exhibited 90% suppression during clamps, FFAs in obese
animals were suppressed by only 70%, suggestive of
adipocyte resistance (Table 2; P  0.004). Diet restriction
appeared to recover insulin’s ability to suppress FFAs in
both obese models, although this recovery, like SI EGP, was
somewhat slower in old animals. Similar results were
obtained for glycerol.
Dependency of SI on adiposity. To determine the de-
pendency of SI on abdominal adiposity, we performed
multiple linear regression analysis to correlate changes in
abdominal fat pads versus whole-body insulin resistance
(1/SI; Fig. 4). Abdominal fat correlated positively with
insulin resistance for young and old rats (P  0.001). The
impact of fat depots classically called visceral fat, epidid-
ymal and perirenal fat was not different for young and old
rats (effect of age epididymal fat: P  0.227, perirenal fat:
P  0.100). In addition, there was no age  fat interaction
for either depot (epididymal fat: P  0.499, perirenal fat:
0.139). In striking contrast, true visceral fat loss, as mea-
sured by the mesenteric depot, exerted a much stronger
effect on insulin sensitivity in young versus old rats (slope:
young: 0.053, old: 0.17 kg/min/mg per % fat; effect of age:
P  0.001; age  fat interaction: P  0.001). Moreover,
mesenteric fat appeared to play a far greater role in
determining SI than did other depots in young rats as
evidenced by more than a doubling of slope, whereas this
increased dependence was not observed with old rats
(slope  0.17). These data suggest not only a stronger
effect of true (i.e., mesenteric) visceral fat in insulin
resistance versus other abdominal depots, but also a
sharply reduced interaction in older animals.
Circulating adipokines and hepatic lipid accumula-
tion. To determine potential mechanisms of this differential
relationship, we measured several circulating adipokines:
adiponectin, resistin, and leptin (Fig. 5A–C). Changes in
neither adiponectin nor resistin appeared to be responsible
for the differential response to caloric restriction in old rats.
As might be expected, leptin levels followed the changes in
absolute adiposity observed in both obese groups, and the
persistently high levels after 6 weeks of caloric restriction in
old rats are likely due to an appreciable degree of remaining
adiposity in these animals.
Because the primary defect in insulin sensitivity resided in
the liver in both obese models, we measured hepatic lipid
content (Fig. 5D). Liver triglyceride reached similar levels in
both young and old rats (young: 608  140 vs. old: 653  95
mg/mg tissue, P  0.05). Astonishingly, reduction of liver
triglyceride with caloric restriction completely mirrored the
delayed recovery in hepatic insulin sensitivity in old rats,
suggesting a defect in lipid turnover in livers of old animals.
DISCUSSION
Recently, our laboratory presented data demonstrating an
increased susceptibility of old rodents to obesity-related
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FIG. 3. Effect of caloric restriction on insulin sensitivity. Whole body
(A), peripheral (B), and hepatic insulin sensitivity (C) in dl/min/kg
body wt (lean body mass for peripheral) per picomolar of insulin 
10
4 as measured by tracer dilution technique during hyperinsuline-
mic-euglycemic clamps in young (E) and old () rats exposed to 0, 2,
4, or 6 weeks of caloric restriction. Dashed lines in each panel
represent the values from control rats for each parameter for compar-
ison. Data are means  SEMs. Statistical signiﬁcance was determined
using two-way ANOVAs for the effect of time and age with post hoc
Tukey tests for individual comparisons. *P < 0.05 for young vs. week 0
and old vs. week 0; §P < 0.05 young vs. old.
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importance of mesenteric fat, true visceral fat in the
rodent, in the manifestation of insulin resistance. Here, we
test the susceptibility hypothesis in more depth by exam-
ining the response to short-term weight loss in young
fat-fed versus old rats. Six weeks of restriction reduced
body weight and abdominal adiposity in both young and
old groups. Remarkably, reductions in mesenteric fat in
old rats exactly mirrored those in young rats, whereas this
similarity did not exist for other abdominal fat depots.
Whole-body insulin sensitivity was markedly improved in
both groups, which signiﬁcantly coincided with a prefer-
ential loss of abdominal fat in both young and old rats.
However, improvement in young rats exhibited a more
than twofold greater dependence on the mesenteric fat
depot versus other abdominal depots. Furthermore, this
association was altered by age such that a similar degree
of mesenteric fat loss led to much lesser amelioration of
insulin resistance in older rats, and slower recovery of
insulin sensitivity in older rats was accompanied by a
remarkably subdued reduction of hepatic triglyceride.
These data support the hypothesis that old animals are at
higher risk for development of insulin resistance in the
face of visceral obesity, which may be coupled with a
defect in hepatic lipid turnover. The corollary is that
adiposity, per se, cannot completely account for the
insulin resistance of the aging rat.
Short-term caloric restriction has been shown to de-
crease both weight and adiposity in other models (16,17).
Interestingly, our data suggest a preferential loss in ab-
dominal depots (30–45%) rather than subcutaneous fat in
both young and old rats with 6 weeks of restriction.
Studies of lifetime caloric restriction have been less apt to
clarify this issue because these animals typically exhibit
marked reduction in all fat depots. Studies looking at
speciﬁc adipose depots have resorted to surgical removal,
such as that reported by Barzilai and colleagues (7,18,19).
These latter studies have examined the effects of gonadal
and perirenal fat removal on SI, depots that do not ﬁt the
speciﬁc criteria of visceral fat, namely circulatory drainage
into the portal vein. To our knowledge, our present study
is the ﬁrst to examine reductions in true visceral (i.e.,
mesenteric) fat as they relate to recovery of SI.
Other studies examining fat distribution during weight
loss have demonstrated a similar preferential diminution
of the visceral depot compared with other adipose depots
(2). Data from our laboratory in dogs have suggested that
the visceral depot may serve as a favored site of fat
accumulation in the early stages of diet-induced obesity
with subsequent fat gain appearing in the periphery once
the visceral depot’s capacity is exhausted (21) (with
further support from [5,22]). Greater loss of visceral
versus subcutaneous depots, as observed in the current
study, might be expected because of the inherently in-
creased lipolytic activity and insulin resistance of visceral
fat (23–26). And although this characteristic of visceral fat
has been used to suggest its importance in the etiology of
insulin resistance, it can equally be exploited to help
explain a potential preferential loss of the tissue in times
of energy deﬁcit.
In contrast to our previous observations, here we ﬁnd
that resistance in young and old obese rats exists primarily
at the liver, rather than the periphery (8). It has been
demonstrated that once Rd and therefore SIR dare ex-
pressed per LBM, the apparent resistance observed in
many studies, especially those examining animals of vari-
ous sizes (i.e., different ages), disappears (27,28). Although
in our previous study LBM was only estimated, here we
use a more precise measure of LBM using a stable isotope.
Furthermore, that fat-fed animals did not exhibit any
substantial peripheral resistance is likely explained by the
fact that these animals were on HFD for less time (3 vs. 4
weeks).
Despite these differences, we found a similar degree of
whole-body insulin resistance as observed previously in
both fat-fed young animals and ad libitum–fed old rats
(50%). More importantly, in concert with fat loss, insulin
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posed to caloric restriction, albeit refractory in old ani-
mals. Our data also demonstrate a highly signiﬁcant
dependence of SI on abdominal fat of all types in both
ages. However reductions in true visceral fat appear to
have a much stronger inﬂuence on attenuating resistance
(Fig. 4) at least in young rats. Tho ¨rne et al. achieve similar
results with surgical removal of visceral fat in obese
patients undergoing gastric banding surgery (29), a result
also observed in the nonobese canine model (30). How-
ever, studies of the removal of subcutaneous fat in humans
have been less clear (31,32). Thus, our data suggest that
visceral fat “removal” reverses insulin resistance whether
induced by diet or age, further suggesting its causative role
in the impairment of insulin action with obesity.
Our data demonstrate a blunted association between
visceral fat loss and the recovery of insulin sensitivity in
old rats, and although this study was not designed to look
at the potential mechanisms for this disparity, several
explanations might exist. Although it is possible that there
is an adipose-independent effect at work in old rats,
regression analysis revealed a signiﬁcant interaction be-
tween age and visceral adiposity for SI (Fig. 4C, P  0.001)
suggesting that “old visceral fat” is different from “young
visceral fat.” Although it is possible that inﬂammatory
cytokines, which are elevated with age (33,34), could
explain this difference, the refractory recovery of SI in old
animals could not be explained by altered regulation of
either adiponectin or resistin. Because the primary site of
resistance in this study was the liver, we must ask what
role the “portal hypothesis” might play in the differences
observed between young and old rats. Old animals ap-
peared to have greater resistance to FFA suppression
during clamp conditions versus young animals, especially
at 2 weeks. However, because this study was not designed
to study lipid turnover directly, it is impossible to discern
the tissue source of these circulating FFAs.
It has been suggested that HFD, such as that used in this
study, induces insulin resistance not through fat depot
accretion, but rather ectopic fat storage (e.g., liver and/or
muscle) (35,36). Here we demonstrate that young and old
obese animals did in fact have similar degrees of fat
accumulation in the liver. Most remarkable was the ﬁnding
that liver triglyceride in old animals, like liver insulin
resistance, reduced more slowly with caloric restriction
versus young fat-fed rats. Our data suggest that old rats do
not mobilize liver triglyceride stores as readily as young,
contributing to their persistent insulin resistance. To test
this, further studies examining hepatic lipid turnover will
be required.
Although caloric restriction reduces adipose mass, it
also has profound effects on eating patterns and insulin-
independent energy balance (37). Furthermore, although
not measured in this study, it cannot be discounted that
there are inherent differences in activity levels between
young and old animals, and the effect that caloric restric-
tion has on activity in each of these age groups may not be
equivalent. Further investigation would be necessary to
clarify these potential differences.
In conclusion, our data demonstrate that short-term diet
restriction is an effective way to reverse insulin resistance
in two obese rat models and this reversal is highly corre-
lated with abdominal fat and hepatic triglyceride loss. In
particular, we have shown that a commonly neglected fat
depot representing true visceral fat in the rodent, the
mesenteric fat pad, has a more than twofold higher
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1422 DIABETES, VOL. 59, JUNE 2010 diabetes.diabetesjournals.orginﬂuence on the improvements in SI observed with restric-
tion. Yet, old animals appear to have a refractory response
to visceral fat loss, suggesting an altered association
between obesity and resistance in old versus young ani-
mals. Although the potential mechanism(s) of this altered
association in young and old animals is not known, our
data suggest that differences in lipid handling by the liver
may be a candidate. Moreover, further investigation into
the potential role of differences in local delivery of adipo-
kines from mesenteric fat will be required.
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